Jacobs Levy Equity Management, Inc Voyager Therapeutics, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 64,524 shares of VYGR stock, worth $188,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,524Holding current value
$188,410% of portfolio
0.0%Shares
15 transactions
Others Institutions Holding VYGR
# of Institutions
121Shares Held
34.6MCall Options Held
12.9KPut Options Held
37.7K-
Armistice Capital, LLC New York, NY5.44MShares$15.9 Million0.28% of portfolio
-
Black Rock Inc. New York, NY5.31MShares$15.5 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$11.4 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$9.38 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.57MShares$7.51 Million0.05% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $113M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...